A study estimates the percentage of US cancer patients eligible for cutting-edge checkpoint inhibitor drugs has skyrocketed from 1.54% in 2011 to 43.63% in 2018. But, the treatment has a success rate of only 20-40% and in some cases, it may cause severe auto-immune reactions. What is the key factor that doctors consider when deciding …
Have you ever wondered why a medication that works wonders for others may not have the same effect on you? Well, it turns out that our genes, lifestyle, and environment all play a role in how our bodies respond to medical treatments. Enter – Genomics (and its tools that enable risk assessment and prediction). Genomics …
Beyond Trial and Error: How Genomics is Personalizing Medicine Read More »
